Abstract

Our objective is to improve the care of patients with malignant disease through: A. investigation of new modalities and optimal utilization of already available modalities, alone and in combination; B. provision of opportunities for study and training in approaches to the problems of patients with cancer; C. and provision of service to patients with malignant diseases. This will be accomplished within the framework of the Southwest Oncology Group whose purposes are: A. to conduct clinical therapeutic trials in patients with neoplastic diseases; B. to report the results of these trials; C. to conduct research which may more generally influence the field of oncology; D. to play an educational role within and beyond the Group.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA003389-29
Application #
3555749
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-01-01
Project End
1988-12-31
Budget Start
1987-01-01
Budget End
1988-12-31
Support Year
29
Fiscal Year
1987
Total Cost
Indirect Cost

  Institution

Name
Tulane University
Department
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118

  Publications

Rivkin, Saul E; Green, Stephanie J; Lew, Danika et al. (2003) Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of Cancer 97:21-9
Saiki, J H; Stuckey, W J; Athens, J W et al. (1993) Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology Group. Invest New Drugs 11:197-200
Harvey, W H; Fleming, T R; Beltran, G et al. (1987) Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study. Cancer Treat Rep 71:1111-2
Stuckey, W J; Crowley, J; Baker, L H et al. (1987) Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study. Cancer Treat Rep 71:1095-6
Morgan, J E; McCaul, D S; Rodriguez, F H et al. (1987) Pulmonary immunologic features of alveolar septal amyloidosis associated with multiple myeloma. Chest 92:704-8
Tranum, B L; Dixon, D; Quagliana, J et al. (1987) Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study. Cancer Treat Rep 71:643-4
Abernathy, D; Beltran, G; Stuckey, W J (1986) Lung cancer following treatment for lymphoma. Am J Med 81:215-8
Temple, J J; Andes, W A (1986) AIDS and Hodgkin's disease. Lancet 2:454-5
Dabich, L; Bull, F E; Beltran, G et al. (1986) Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. Cancer Treat Rep 70:967-9
Dana, B W; Jones, S E; Coltman, C et al. (1986) Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study. Cancer Treat Rep 70:291-2

Showing the most recent 10 out of 13 publications